Cargando…
Preclinical and clinical activity of DZD1516, a full blood–brain barrier-penetrant, highly selective HER2 inhibitor
BACKGROUND: Patients with HER2-positive metastatic breast cancer (MBC) are at high risk of developing central nervous system (CNS) metastases. A potent and selective HER2 inhibitor with good blood–brain barrier (BBB) penetration is highly desirable. METHODS: The design and structure–activity relatio...
Autores principales: | Zhang, Jian, McAndrew, Nicholas P., Wang, Xiaojia, Du, Yiqun, DiCarlo, Brian, Wang, Mei, Chen, Kan, Yu, Wenlei, Hu, Xichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327353/ https://www.ncbi.nlm.nih.gov/pubmed/37415239 http://dx.doi.org/10.1186/s13058-023-01679-4 |
Ejemplares similares
-
A(2A)R Antagonism with DZD2269 Augments Antitumor Efficacy of Irradiation in Murine Model
por: Huang, Jiaqi, et al.
Publicado: (2020) -
Argentina 1516-1987 : desde la colonización española hasta Alfonsín /
por: Rock, David, 1945-
Publicado: (1988) -
ent-(15S)-Pimar-8(14)-ene-15,16-diol
por: Fun, Hoong-Kun, et al.
Publicado: (2012) -
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
por: Bai, Yu, et al.
Publicado: (2022) -
El Bosco, 1450(?)-1516 : entre el cielo y el infierno /
por: Bosing, Walter
Publicado: (1974)